Ensign Lifts 2026 EPS Guidance to $7.94-$8.02 After Q3 EPS Jumped 23.9%
ENSG sits 18% above its 52-week low of $141.58 on elevated volume (2.0× avg).
Summary
Ensign posted Q3 revenue of $1.48 billion (+14.5%) and diluted EPS of $1.76 (+23.9%), then raised 2026 EPS guidance to $7.94-$8.02 from $7.75-$7.85 while adding 22 new operations.
Key Events · Earnings and Guidance · ENSG
-
Q3 Earnings Beat and Guidance Raised
GAAP diluted EPS of $1.76 rose 23.9% and adjusted EPS of $2.03 rose 23.8%; 2026 EPS guidance was raised to $7.94-$8.02 from $7.75-$7.85, with the midpoint 21.5% above 2025.
-
Revenue Up 14.5%, Margins Expand
Total revenue reached $1,484.0 million from $1,296.4 million; cost of services fell to 78.6% of revenue from 80.6%, lifting income from operations to $138.0 million from $96.2 million.
-
22 New Operations Added
Ensign added 22 operations during and since the quarter (3 real estate assets, 19 leased), including its Florida entry, and acquired the real estate of five previously leased facilities totaling 755 skilled nursing beds.
-
Liquidity and Capital Position
Cash was $337.6 million with $731.6 million of available line-of-credit capacity; Standard Bearer rental revenue rose 46.3% to $47.7 million and FFO rose 41.3% to $27.3 million.
Analysis · ENSG · Industrial Applications And Services
Ensign beat its own plan in Q3 and pulled full-year earnings guidance up to $7.94-$8.02 per diluted share from $7.75-$7.85, with the midpoint now implying 21.5% growth over 2025. Revenue rose 14.5% to $1.48 billion while cost of services fell to 78.6% of revenue from 80.6%, so operating income nearly jumped by half to $138.0 million. The company also kept buying: 22 new operations added during and since the quarter, including its entry into Florida, funded from $337.6 million of cash and $731.6 million of undrawn credit. The offset is a securities class action filed October 8, 2026, disclosed in the accompanying 10-Q, which keeps a litigation overhang on an otherwise strong quarter.
How filings like this one have moved
In the 30 days to Oct 27, 2026, 29.9% of the 1374 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.12%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ENSG was trading at $167.11 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $9.9B. The 52-week trading range was $141.58 to $218.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.